Drugs that contain Tazarotene

1. List of Arazlo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11311482 BAUSCH Topical compositions and methods for treating skin diseases
May, 2038

(14 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Dec 18, 2022

Market Authorisation Date: 18 December, 2019

Treatment: Topical treatment of acne vulgaris in patients 9 years of age and older

Dosage: LOTION;TOPICAL

How can I launch a generic of ARAZLO before it's patent expiration?
More Information on Dosage

ARAZLO family patents

13

United States

2

Brazil

2

Canada

2

Japan

2

European Union

1

Australia

1

China

1

RS

1

Denmark

1

Croatia

1

Poland

1

Slovenia

1

Lithuania

1

Korea, Republic of

1

Hungary

1

Portugal

1

Spain

1

Mexico

2. List of Fabior drug patents

FABIOR Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10568859 MAYNE PHARMA Topical foam composition
Feb, 2030

(6 years from now)

US10688071 MAYNE PHARMA Topical foam composition
Feb, 2030

(6 years from now)

US8808716 MAYNE PHARMA Topical foam composition
Feb, 2030

(6 years from now)

Market Authorisation Date: 11 May, 2012

Treatment: Topical treatment of acne vulgaris in patients 12 years of age or older

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage

FABIOR family patents

5

United States

2

Australia

2

Japan

EA

1

EA

1

Brazil

1

Chile

1

Spain

1

Denmark

1

South Africa

1

Poland

1

Canada

1

Portugal

1

Korea, Republic of

1

China

1

Singapore

1

Israel

1

Mexico

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic